Company intelligence / Profile preview

Pacific Bioengineering

New Delhi, Delhi, India

Ownership: Private
Development stage: Other

Overview

Pacific Bioengineering Private Limited is an Indian pharmaceutical company specializing in the development, manufacturing, and supply of therapeutic formulations. The company focuses on critical health areas, particularly cardiovascular wellness, metabolic disorders, and nutritional supplements. Its commercial product portfolio includes Valsafic (sacubitril/valsartan) for heart failure, Metrofic (metoprolol succinate) for hypertension, and Mecofic (methylcobalamin) for vitamin B12 deficiency. Operating with WHO-GMP certified manufacturing standards, Pacific Bioengineering integrates advanced pharmaceutical science to deliver high-quality, patient-focused clinical solutions.

Therapeutic areas: CardiovascularHematologyEndocrinology
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Pacific Bioengineering.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pacific Bioengineering.

Explore the full profile